End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015

Description:

Research Beam added a report on “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015” Enquiry about report: – PowerPoint PPT presentation

Number of Views:34

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015


1
End-Stage Kidney Disease (End-Stage Renal Disease
or ESRD) Global Clinical Trials Review, H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE 1 (503) 894-6022E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview
  • End-Stage Kidney Disease (End-Stage Renal Disease
    or ESRD) Global Clinical Trials Review, H2, 2015
    provides an overview of End-Stage Kidney Disease
    (End-Stage Renal Disease or ESRD) clinical trials
    scenario. This report provides top line data
    relating to the clinical trials on End-Stage
    Kidney Disease (End-Stage Renal Disease or ESRD)
    . Report includes an overview of trial numbers
    and their average enrollment in top countries
    conducted across the globe. The report offers
    coverage of disease clinical trials by region,
    country (G7 E7) , phase, trial status, end
    points status and sponsor type. Report also
    provides prominent drugs for in-progress trials
    (based on number of ongoing trials) .
  • Scope
  • The report provides a snapshot of the global
    clinical trials landscape
  • Report provides top level data related to the
    clinical trials by Region, Country (G7 E7) ,
    Trial Status, Trial Phase, Sponsor Type and End
    point status
  • The report reviews top companies involved and
    enlists all trials (Trial title, Phase, and
    Status) pertaining to the company
  • The report provides all the unaccomplished trials
    (Terminated, Suspended and Withdrawn) with reason
    for unaccomplishment
  • The Report provides enrollment trends for the
    past five years
  • Report provides latest news for the past three
    months
  • Read More At http//www.researchbeam.com/end-st
    age-kidney-disease-end-stage-renal-disease-or-esrd
    -global-clinical-trials-review-h2-2015-market

3


Table of Content
Table of Contents 2List of Tables 4List of
Figures 6Introduction 7End-Stage Kidney Disease
(End-Stage Renal Disease or ESRD) 7Report
Guidance 7Clinical Trials by Region 8Clinical
Trials and Average Enrollment by Country 9Top
Five Countries Contributing to Clinical Trials in
Asia-Pacific 11Top Five Countries Contributing
to Clinical Trials in Europe 12Top Countries
Contributing to Clinical Trials in North America
13Top Five Countries Contributing to Clinical
Trials in Middle East and Africa 14Top Five
Countries Contributing to Clinical Trials in
Central and South America 15Clinical Trials by
G7 Countries Proportion of End-Stage Kidney
Disease (End-Stage Renal Disease or ESRD) to
Genito Urinary System And Sex Hormones Clinical
Trials 16Clinical Trials by Phase in G7
Countries 17Clinical Trials in G7 Countries by
Trial Status 18Clinical Trials by E7 Countries
Proportion of End-Stage Kidney Disease (End-Stage
Renal Disease or ESRD) to Genito Urinary System
And Sex Hormones Clinical Trials 19Clinical
Trials by Phase in E7 Countries 20Clinical
Trials in E7 Countries by Trial Status 21
4


Report Overview
Reasons to buyAssists in formulating key
business strategies with regards to
investment Helps in identifying prominent
locations for conducting clinical trials which
saves time and cost Provides top level analysis
of Global Clinical Trials Market which helps in
identifying key business opportunities Supports
understanding of trials count and enrollment
trends by country in global therapeutics
market  Aids in interpreting the success rates
of clinical trials by providing a comparative
scenario of completed and uncompleted
(terminated, suspended or withdrawn)
trials Facilitates clinical trial assessment of
the indication on a global, regional and country
level Enquire At http//www.researchbeam.com/
end-stage-kidney-disease-end-stage-renal-disease-o
r-esrd-global-clinical-trials-review-h2-2015-marke
t/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/end-stage-kidney-disea
se-end-stage-renal-disease-or-esrd-global-clinical
-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (800) 910-6452 DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com
About PowerShow.com